Original Article

You have full text access to this OnlineOpen article

Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma

  1. Ryota Tanaka M.D.1,2,
  2. Daye Wang Ph.D.2,
  3. Yukio Morishita M.D.2,
  4. Yukinori Inadome M.D.2,
  5. Yuko Minami M.D.2,
  6. Tatsuo Iijima M.D.2,
  7. Shimao Fukai M.D.3,
  8. Tomoyuki Goya M.D.1,
  9. Masayuki Noguchi M.D.2,†,*

Article first published online: 20 DEC 2004

DOI: 10.1002/cncr.20827

Issue

Cancer

Cancer

Volume 103, Issue 3, pages 608–615, 1 February 2005

Additional Information

How to Cite

Tanaka, R., Wang, D., Morishita, Y., Inadome, Y., Minami, Y., Iijima, T., Fukai, S., Goya, T. and Noguchi, M. (2005), Loss of function of p16 gene and prognosis of pulmonary adenocarcinoma. Cancer, 103: 608–615. doi: 10.1002/cncr.20827

Author Information

  1. 1

    Department of Surgery II, Institute of Medical Sciences, Kyorin University, Tokyo, Japan

  2. 2

    Department of Pathology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan

  3. 3

    Department of Surgery, Ibarakihigashi National Hospital, Ibaraki, Japan

  1. †

    Fax: (011) 81-29-853-3150

*Department of Pathology, Graduate School of Comprehensive Human Sciences, University of Tsukuba, 1-1-1 Tennodai, Tsukuba-shi, Ibaraki 305-8575, Japan

Publication History

  1. Issue published online: 20 JAN 2005
  2. Article first published online: 20 DEC 2004
  3. Manuscript Accepted: 18 OCT 2004
  4. Manuscript Revised: 3 OCT 2004
  5. Manuscript Received: 14 JUN 2004

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (345K)

REFERENCES

  • 1
    Travis WD, Colby TV, Corrin B, Shimosato Y, Brambilla E. Histological typing of lung and pleural tumours. Berlin: Springer Verlag, 1999.
  • 2
    Noguchi M, Morikawa A, Kawasaki M, et al. Small adenocarcinoma of the lung—histologic characteristics and prognosis. Cancer. 1995; 75: 2844–2852.
    Direct Link:
  • 3
    Gazzeri S, Gouyer V, Vourc'h C, Brambilla C, Brambilla E. Mechanisms of p16(INK4A) inactivation in non small-cell lung cancers. Oncogene. 1998; 16: 497–504.
  • 4
    Nobori T, Miura K, Wu DJ, Lois A, Takabayashi K, Carson DA. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature. 1994; 368: 753–756.
  • 5
    Kamb A, Gruis NA, Weaverfeldhaus J, et al. A cell-cycle regulator potentially involved in genesis of many tumor types. Science. 1994; 264: 436–440.
  • 6
    Merlo A, Herman JG, Mao L, et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumor-suppressor p16/CDKN2/MTS1 in human cancers. Nature Med. 1995; 1: 686–692.
  • 7
    Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest. 1997; 111: 1710–1717.
  • 8
    Goelz SE, Hamilton SR, Vogelstein B. Purification of DNA from formaldehyde fixed and paraffin embedded human tissue. Biochem Biophys Res Commun. 1985; 130: 118–126.
  • 9
    Herman JG, Graff JR, Myohanen S, Nelkin BD, Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA. 1996; 93: 9821–9826.
  • 10
    Palmisano WA, Divine KK, Saccomanno G, et al. Predicting lung cancer by detecting aberrant promoter methylation in sputum. Cancer Res. 2000; 60: 5954–5958.
  • 11
    Suter CM, Norrie M, Ku SL, Cheong KF, Tomlinson I, Ward RL. CpG island methylation is a common finding in colorectal cancer cell lines. Br J Cancer. 2003; 88: 413–419.
  • 12
    Zhu W, Zou H, Beck A, et al. Loss of heterozygosity in primary lung cancer using laser capture microdissection and WAVE DNA fragment analysis techniques. Med Sci Monit. 2002; 8: BR95–BR99
  • 13
    Kurasono Y, Ito T, Kameda Y, Nakamura N, Kitamura H. Expression of cyclin D1, retinoblastoma gene protein, and p16 MTS1 protein in atypical adenomatous hyperplasia and adenocarcinoma of the lung—an immunohistochemical analysis. Virchows Arch. 1998; 432: 207–215.
  • 14
    Semczuk A, Boltze C, Marzec B, Szczygielska A, Roessner A, Schneider-Stock R. p16(INK4A) alterations are accompanied by aberrant protein immunostaining in endometrial carcinomas. J Cancer Res Clin Oncol. 2003; 129: 589–596.
  • 15
    Belinsky SA, Nikula KJ, Palmisano WA, et al. Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis. Proc Natl Acad Sci USA. 1998; 95: 11891–11896.
  • 16
    Wistuba II, Behrens C, Milchgrub S, et al. Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma. Oncogene. 1999; 18: 643–650.
  • 17
    Toyooka S, Maruyama R, Toyooka KO, et al. Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. Int J Cancer. 2003; 103: 153–160.
    Direct Link:
View Full Article (HTML) Get PDF (345K)